Allergic rhinitis is a prevalent and bothersome condition affecting millions of individuals worldwide, characterized by nasal congestion, sneezing, and rhinorrhea due to allergen exposure. Traditional treatments often provide symptomatic relief but may have limitations. In pursuit of improved therapeutic options, this study explores the development and pharmaceutical evaluation of novel thermos-reversible in-situ nasal gel formulations containing extracts derived from Adina cordifolia leaves and Sida spinosa leaves